BIB_137
BCAAs and metabolic enzymes in tumour development — review. Cancer Letters 2026. PMID 41769003. BCAAs activate mTORC1/PI3K/AKT; mixed pro- and anti-tumour effects depending on context; no melanoma-specific human outcome data. [Tasks: 13] Tier: 3 Grade: C Retrieved: 2026-05-07
- Evidence grade
- C
- Tier
- 3
- Cited by tasks
- 13
- Identifiers
- PMID:41769003
↗ Follow the original source for full context
Full extracted findings & patient-implication analysis: bibliography/BIB_137/findings.md (research corpus). This page is a short context summary — not individualised medical advice.